Skip to content
sellWeak cluster of 3

Nicholas Hollmeyer Lynton sold $7,316 of CDLX

Chief Legal & Privacy Officer at Cardlytics, Inc.. 6,253 shares at an average of $1.17, traded Jan 5, 2026, filed Jan 5, 2026.

Warning score
15
Value
$7,316
6,253 shares
Holdings after
122,862
-5% from before
From 52-week low
+39%
low $8.90, close $12.40
From 52-week high
-68%
high $39.00, as of Jan 5, 2026

Score components

  • Role
    Officer
    +15
  • Trade size
    $7k at market
    0
  • Share of holdings sold
    Sold 4.8% of holdings
    0
  • Cluster
    3 insiders selling within 14 days
    +15
  • Exercise and sell
    Shares came from an option exercise in the same filing
    -15

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

CDLXOct 9, 2026 · close 2.06
Since filing Jan 5, 2026: -83.4%SPY +14.1% · excess -97.5%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001628280-26-000727, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Jan 1, 2026MOption exercise
Common Stock
+581--116,908Jan 5, 2026
Jan 1, 2026MOption exercise
Common Stock
+1,578--118,486Jan 5, 2026
Jan 1, 2026MOption exercise
Common Stock
+10,629--129,115Jan 5, 2026
Jan 5, 2026SOpen-market sale
Common Stock
-6,253$1.17$7,316122,862Jan 5, 2026
Jan 1, 2026MOption exercise
Restricted Stock Unitderivative
-581$0.00$0582Jan 5, 2026
Jan 1, 2026MOption exercise
Restricted Stock Unitsderivative
-1,578$0.00$03,156Jan 5, 2026
Jan 1, 2026MOption exercise
Restricted Stock Unitderivative
-10,629$0.00$010,630Jan 5, 2026

Related signals

Other insiders at Cardlytics, Inc. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
21Weak
CDLXsell
Cardlytics, Inc.
Amit Gupta
Chief Executive Officer
$47k
17,733 shares
-11%
24Weak
CDLXsell
Cardlytics, Inc.
Amit Gupta
Chief Executive Officer
$89k
97,208 shares
-13%
22Weak
CDLXsell 3
Cardlytics, Inc.
Alexis DeSieno
Chief Financial Officer
$10k
8,607 shares
-4%
25Weak
CDLXsell 3
Cardlytics, Inc.
Amit Gupta
Chief Executive Officer
$6,794
5,807 shares
-1%
22Weak
CDLXsell 3
Cardlytics, Inc.
Alexis DeSieno
Chief Financial Officer
$19k
8,493 shares
-4%
25Weak
CDLXsell 3
Cardlytics, Inc.
Amit Gupta
Chief Executive Officer
$18k
7,799 shares
-2%
15Weak
CDLXsell 3
Cardlytics, Inc.
Nicholas Hollmeyer Lynton
Chief Legal & Privacy Officer
$14k
6,098 shares
-5%
44Moderate
CDLXsell 3
Cardlytics, Inc.
Clifford Sosin
owner
$453k
400,000 shares
-7%
41Moderate
CDLXsell 3
Cardlytics, Inc.
Amit Gupta
Chief Executive Officer
$154k
136,945 shares
-22%
32Weak
CDLXsell 3
Cardlytics, Inc.
Alexis DeSieno
Chief Financial Officer
$32k
26,048 shares
-12%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Nicholas Hollmeyer Lynton sold $7,316 of CDLX | InsiderTell